Introduction: . Materials & Methods: ) gene. Scaffold release kinetics were characterized, and antifungal efficacy was assessed using minimum inhibitory concentration (MIC) assays. Results: gene expression. MIC values for PVA-NYS-THY, PVA-NYS, and PVA-THY were 7.81, 15.62, and 62.5 µg/mL, respectively, demonstrating superior antifungal activity of the PVA-NYS-THY formulation. Conclusion: , providing a novel solution to overcome current limitations in antifungal treatment.
Romina et al. (Mon,) studied this question.